Zhijun Zhang

Prof. Zhijun Zhang

Shanghai Jiaotong University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Theranostics
Verified
Journal Article
Open access
YSYaying Song
Yaying Song
ZLZongwei Li
Zongwei Li
THTingting He
Tingting He
MQMeijie Qu
Meijie Qu
LJLu Jiang
Lu Jiang
YGYang Guo-Yuan
Yang Guo-Yuan
Rationale: Microglia play a critical role in modulating cell death and neurobehavioral recovery in response to brain injury either by direct cell-cell interaction or indirect secretion of trophic factors. Exosomes secreted from cells are well documented to deliver bioactive molecules to recipient cells to modulate cell function. Here, we aimed to identify whether M2 microglia exert neuroprotection after ischemic attack through an exosome-mediated cell-cell interaction.

1 January 2020 in Theranostics
Verified
Journal Article
Open access
LZLin-Yuan Zhang
Lin-Yuan Zhang
JPJiaji Pan
Jiaji Pan
MMMuyassar Mamtilahun
Muyassar Mamtilahun
YZYuan Zhu
Yuan Zhu
LWLiping Wang
Liping Wang
YGYang Guo-Yuan
Yang Guo-Yuan
Microglial activation participates in white matter injury after cerebral hypoperfusion. However, the underlying mechanism is unclear. Here, we explore whether activated microglia aggravate white matter injury via complement C3-C3aR pathway after chronic cerebral hypoperfusion.

1 January 2021 in Theranostics
Verified
Journal Article
Open access
ZLZongwei Li
Zongwei Li
YSYaying Song
Yaying Song
THTingting He
Tingting He
RWRuoxue Wen
Ruoxue Wen
YLYongfang Li
Yongfang Li
ZZZhijun Zhang
Zhijun Zhang
Rationale: Glial scars present a major obstacle for neuronal regeneration after stroke. Thus, approaches to promote their degradation and inhibit their formation are beneficial for stroke recovery. The interaction of microglia and astrocytes is known to be involved in glial scar formation after stroke; however, how microglia affect glial scar formation remains unclear.

1 January 2022 in Theranostics
Verified
Journal Article
Open access
YLYongfang Li
Yongfang Li
ZLZe Liu
Ze Liu
YSYaying Song
Yaying Song
JPJia-Ji Pan
Jia-Ji Pan
YJYixu Jiang
Yixu Jiang
YGYang Guo-Yuan
Yang Guo-Yuan
Rationale: White matter repair is critical for the cognitive and neurological functional recovery after ischemic stroke. M2 microglia are well-documented to enhance remyelination and their extracellular vesicles (EVs) mediate cellular function after brain injury. However, whether M2 microglia-derived EVs could promote white matter repair after cerebral ischemia and its underlying mechanism are largely unknown.

3 May 2018 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
ZCZhuo Cheng
Zhuo Cheng
LWLiping Wang
Liping Wang
MQMeijie Qu
Meijie Qu
HLHuaibin Liang
Huaibin Liang
WLWanlu Li
Wanlu Li
YGYang Guo-Yuan
Yang Guo-Yuan
Ischemic stroke induced matrixmetallo-proteinase-9 (MMP-9) upregulation, which increased blood-brain barrier permeability. Studies demonstrated that mesenchymal stem cell therapy protected blood-brain barrier disruption from several cerebrovascular diseases. However, the underlying mechanism was largely unknown. We therefore hypothesized that mesenchymal stem cells reduced blood-brain barrier destruction by inhibiting matrixmetallo-proteinase-9 and it was related to intercellular adhesion molecule-1 (ICAM-1). Adult ICR male mice (n = 118) underwent 90-min middle cerebral artery occlusion and received 2 × 105 mesenchymal stem cell transplantation. Neurobehavioral outcome, infarct volume, and blood-brain barrier permeability were measured after ischemia. The relationship between myeloperoxidase (MPO) activity and ICAM-1 release was further determined. We found that intracranial injection of mesenchymal stem cells reduced infarct volume and improved behavioral function in experimental stroke models (p < 0.05). IgG leakage, tight junction protein loss, and inflammatory cytokines IL-1β, IL-6, and TNF-α reduced in mesenchymal stem cell-treated mice compared to the control group following ischemia (p < 0.05). After transplantation, MMP-9 was decreased in protein and activity levels as compared with controls (p < 0.05). Furthermore, myeloperoxidase-positive cells and myeloperoxidase activity were decreased in mesenchymal stem cell-treated mice (p < 0.05). The results showed that mesenchymal stem cell therapy attenuated blood-brain barrier disruption in mice after ischemia. Mesenchymal stem cells attenuated the upward trend of MMP-9 and potentially via downregulating ICAM-1 in endothelial cells. Adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK) pathway may influence MMP-9 expression of neutrophils and resident cells, and ICAM-1 acted as a key factor in the paracrine actions of mesenchymal stem cell.

10 March 2020 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
PDF file
RWRuo‐Xue Wen
Ruo‐Xue Wen
HSHui Shen
Hui Shen
SHShu‐Xian Huang
Shu‐Xian Huang
LWLi‐Ping Wang
Li‐Ping Wang
ZLZong‐Wei Li
Zong‐Wei Li
ZZZhijun Zhang
Zhijun Zhang
Introduction: Clearance of damaged cells and debris is beneficial for the functional recovery after ischemic brain injury. However, the specific phagocytic receptor that mediates microglial phagocytosis after ischemic stroke is unknown.Aim: To investigate whether P2Y6 receptor‐mediated microglial phagocytosis is beneficial for the debris clearance and functional recovery after ischemic stroke.Results: The expression of the P2Y6 receptor in microglia increased within 3 days after transient middle cerebral artery occlusion. Inhibition of microglial phagocytosis by the selective inhibitor MRS2578 enlarged the brain atrophy and edema volume after ischemic stroke, subsequently aggravated neurological function as measured by modified neurological severity scores and Grid walking test. MRS2578 treatment had no effect on the expression of IL‐1α, IL‐1β, IL‐6, IL‐10, TNF‐α, TGF‐β, and MPO after ischemic stroke. Finally, we found that the expression of myosin light chain kinase decreased after microglial phagocytosis inhibition in the ischemic mouse brain, which suggested that myosin light chain kinase was involved in P2Y6 receptor‐mediated phagocytosis.Conclusion: Our results indicate that P2Y6 receptor‐mediated microglial phagocytosis plays a beneficial role during the acute stage of ischemic stroke, which can be a therapeutic target for ischemic stroke.